Page last updated: 2024-08-21

quinazolines and Neurilemoma

quinazolines has been researched along with Neurilemoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abbadi, S; Blakeley, JO; Bonne, N; Brem, H; Giovannini, M; Itzoe, M; Paldor, I; Rodriguez, FJ; Rowshanshad, D; Tyler, BM; Vigilar, V; Ye, X1
Bracho, O; Burns, SS; Chang, LS; Copik, AJ; Dinh, CT; Fernandez-Valle, C; Franco, MC; Fuse, MA; Liu, XZ; Mittal, R; Plati, SK; Shen, R; Soulakova, JN; Telischi, FF; Yan, D1
Chan, AW; di Tomaso, E; Jain, RK; Kamoun, WS; Lahdenranta, J; McClatchey, AI; Plotkin, SR; Wong, HK1
Beham, A; Bodo, K; Lackner, K; Liegl, B; Martin, D; Tsybrovskyy, O1

Other Studies

4 other study(ies) available for quinazolines and Neurilemoma

ArticleYear
The efficacy of lapatinib and nilotinib in combination with radiation therapy in a model of NF2 associated peripheral schwannoma.
    Journal of neuro-oncology, 2017, Volume: 135, Issue:1

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cell Line, Tumor; Cell Survival; Chemoradiotherapy; Everolimus; Lapatinib; Mice; Mice, Nude; Mice, Transgenic; Models, Statistical; Neoplasm Transplantation; Neurilemmoma; Neurofibromatosis 2; Peripheral Nervous System Neoplasms; Pyrimidines; Quinazolines; Sciatic Nerve; Time Factors

2017
Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells.
    Molecular cancer therapeutics, 2017, Volume: 16, Issue:11

    Topics: Anilides; Animals; Apoptosis; Benzodioxoles; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Dasatinib; Humans; Mice; Neurilemmoma; Neurofibromin 2; Proto-Oncogene Proteins c-met; Pyridines; Quinazolines; Schwann Cells; src-Family Kinases; Xenograft Model Antitumor Assays

2017
Anti-vascular endothelial growth factor therapies as a novel therapeutic approach to treating neurofibromatosis-related tumors.
    Cancer research, 2010, May-01, Volume: 70, Issue:9

    Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain Neoplasms; Cell Growth Processes; Cell Line, Tumor; Humans; Mice; Mice, Nude; Neovascularization, Pathologic; Neurilemmoma; Neurofibromatosis 2; Neurofibromin 2; Piperidines; Quinazolines; Vascular Endothelial Growth Factor A

2010
Microcystic/reticular schwannoma of the pancreas: a potential diagnostic pitfall.
    Pathology international, 2011, Volume: 61, Issue:2

    Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biopsy, Fine-Needle; Deoxycytidine; Diagnostic Errors; Erlotinib Hydrochloride; Fatal Outcome; Gemcitabine; Humans; Immunohistochemistry; Male; Middle Aged; Neoadjuvant Therapy; Neurilemmoma; Pancreatectomy; Pancreatic Neoplasms; Quinazolines

2011